Singapore, April 1 -- Even with significant advancements, there are still a number of issues with cell therapy manufacturing that need to be resolved as production grows.

Cancer research has come a long way. Along with technology advancements, the basic options for treating cancer, such as surgery, radiation, and chemotherapy, have expanded their mainstays when immunotherapy is developed. Individualised CAR-T cell therapy uses a patient's immune system to fight specific types of cancers or a broad spectrum of immuno-oncology and infectious diseases. Cell-based therapies aim to treat diseases by altering or restoring certain sets of cells or using cells to carry a therapy through the body.

Despite substantial progress in this field, cel...